8-Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease

被引:246
作者
Choe, Leila
D'Ascenzo, Mark
Relkin, Norman R.
Pappin, Darryl
Ross, Philip
Williamson, Brian
Guertin, Steven
Pribil, Patrick
Lee, Kelvin H.
机构
[1] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY USA
[2] Cornell Univ, Coll Med, Dept Neurol & Neurosci, New York, NY USA
[3] Appl Biosyst Inc, Framingham, MA USA
[4] MDS Sciex, Concord, ON, Canada
关键词
alzheimer's disease; cerebrospinal fluid; immunotherapy; iTRAQ; shotgun proteomics;
D O I
10.1002/pmic.200700316
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An 8-plex version of an isobaric reagent for the quantitation of proteins using shotgun methods is presented. The 8-plex version of the reagent relies on amine-labeling chemistry of peptides similar to 4-plex reagents. MS/MS reporter ions at 113, 114, 115, 116, 117, 118, 119, and 121 m/z are used to quantify protein expression. This technology which was first applied to a test mixture consisting of eight proteins and resulted in accurate quantitation, has the potential to increase throughput of analysis for quantitative shotgun proteomics experiments when compared to 2-and 4-plex methods. The technology was subsequently applied to a longitudinal study of cerebrospinal fluid (CSF) proteins from subjects undergoing intravenous Ig treatment for Alzheimer's disease. Results from this study identify a number of protein expression changes that occur in CSF after 3 and 6 months of treatment compared to a baseline and compared to a drug washout period. A visualization tool was developed for this dataset and is presented. The tool can aid in the identification of key peptides and measurements. One conclusion aided by the visualization tool is that there are differences in considering peptide-based observations versus protein-based observations from quantitative shotgun proteomics studies.
引用
收藏
页码:3651 / 3660
页数:10
相关论文
共 18 条
  • [1] Quantitative analysis of protein expression using amine-specific isobaric tags in Escherichia coli cells expressing rhsA elements
    Aggarwal, K
    Choe, LH
    Lee, KH
    [J]. PROTEOMICS, 2005, 5 (09) : 2297 - 2308
  • [2] Alpha-2 macroglobulin is genetically associated with Alzheimer disease
    Blacker, D
    Wilcox, MA
    Laird, NM
    Rodes, L
    Horvath, SM
    Go, RCP
    Perry, R
    Watson, B
    Bassett, SS
    McInnis, MG
    Albert, MS
    Hyman, BT
    Tanzi, RE
    [J]. NATURE GENETICS, 1998, 19 (04) : 357 - 360
  • [3] Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects
    Castaño, EM
    Roher, AE
    Esh, CL
    Kokjohn, TA
    Beach, T
    [J]. NEUROLOGICAL RESEARCH, 2006, 28 (02) : 155 - 163
  • [4] Quantitative and qualitative measure of intralaboratory two-dimensional protein gel reproducibility and the effects of sample preparation, sample load, and image analysis
    Choe, LH
    Lee, KH
    [J]. ELECTROPHORESIS, 2003, 24 (19-20) : 3500 - 3507
  • [5] Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer's disease
    Dodel, RC
    Du, Y
    Depboylu, C
    Hampel, H
    Frölich, L
    Haag, A
    Hemmeter, U
    Paulsen, S
    Teipel, SJ
    Brettschneider, S
    Spottke, A
    Nölker, C
    Möller, HJ
    Wei, X
    Farlow, M
    Sommer, N
    Oertel, WH
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (10) : 1472 - 1474
  • [6] Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases
    Eder, U
    Leitner, B
    Kirchmair, R
    Pohl, P
    Jobst, KA
    Smith, AD
    Málly, J
    Benzer, A
    Riederer, P
    Reichmann, H
    Saria, A
    Winkler, H
    [J]. JOURNAL OF NEURAL TRANSMISSION, 1998, 105 (01) : 39 - 51
  • [7] Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease
    Finehout, Erin J.
    Franck, Zsofia
    Choe, Leila H.
    Relkin, Norman
    Lee, Kelvin H.
    [J]. ANNALS OF NEUROLOGY, 2007, 61 (02) : 120 - 129
  • [8] Fishman R.A., 1992, CEREBROSPINAL FLUID, V2nd
  • [9] Prediction of error associated with false-positive rate determination for peptide identification in large-scale proteomics experiments using a combined reverse and forward peptide sequence database strategy
    Huttlin, Edward L.
    Hegeman, Adrian D.
    Harms, Amy C.
    Sussman, Michael R.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2007, 6 (01) : 392 - 398
  • [10] Proteomics: a technology-driven and technology-limited discovery science
    Lee, KH
    [J]. TRENDS IN BIOTECHNOLOGY, 2001, 19 (06) : 217 - 222